Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer()

OBJECTIVE: Our goal was to evaluate the effects of simvastatin on endometrial cancer cell lines and primary cultures of endometrial cancer cells. METHODS: Cell proliferation in the ECC-1 and Ishikawa endometrial cancer cell lines and primary cultures of endometrial cancer cells was assessed by MTT a...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Schointuch, Monica N., Gilliam, Timothy P., Stine, Jessica E., Han, Xiaoyun, Zhou, Chunxiao, Gehrig, Paola A., Kim, Kenneth, Bae-Jump, Victoria L.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4125536/
https://ncbi.nlm.nih.gov/pubmed/24880141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2014.05.015
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky